NCT03515603

Brief Summary

Prospective and randomized compare between microsurgical and endoscopic transsphenoidal MRI assisted resection of pituitary adenomas.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 14, 2018

Completed
19 days until next milestone

First Posted

Study publicly available on registry

May 3, 2018

Completed
7 days until next milestone

Study Start

First participant enrolled

May 10, 2018

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

May 17, 2023

Status Verified

May 1, 2023

Enrollment Period

4.6 years

First QC Date

April 14, 2018

Last Update Submit

May 14, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • endocrine function

    Testing of pituitary function with insulin-hypoglycemic test, results will be dichotomized as satisfactory or not satisfactory. Satisfactory outcome is defined, if pituitary function improves or is stable, if compared to preoperative testing.

    1 year after surgery

Secondary Outcomes (2)

  • Extent of resection

    tumor volume before the surgery, 3 months after surgery

  • Quality of Life, EQ-5D

    3 months and 1 year after surgery

Study Arms (2)

microsurgical technique

ACTIVE COMPARATOR
Procedure: Microsurgical resection

endoscopic technique

ACTIVE COMPARATOR
Procedure: Endoscopic resection

Interventions

Transsphenoidal endoscopic resection of pituitary adenoma

endoscopic technique

Transsphenoidal microsurgical resection of pituitary adenoma

microsurgical technique

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Suspected symptomatic or progressively growing pituitary adenoma
  • Informed consent

You may not qualify if:

  • Prolactinoma
  • No follow-up possible
  • Emergency surgery without informed consent or without intraoperative MRI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Neurosurgery

Günzburg, 89312, Germany

Location

Related Publications (1)

  • Pala A, Grubel N, Mayer B, Becker R, Sommer F, Schmitz B, Etzrodt-Walter G, Wirtz CR, Hlavac M. Endocrine Outcome and Quality of Life After Transsphenoidal Resection of Pituitary Adenoma-A Prospective Randomized Single-Blinded Study Comparing Endoscopic Versus Microscopic Resection. Neurol Int. 2025 Jan 10;17(1):5. doi: 10.3390/neurolint17010005.

MeSH Terms

Conditions

Pituitary Neoplasms

Interventions

Endoscopic Mucosal Resection

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHypothalamic NeoplasmsSupratentorial NeoplasmsBrain NeoplasmsCentral Nervous System NeoplasmsNervous System NeoplasmsBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesHypothalamic DiseasesPituitary DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Andrej Pala, MD

    University Ulm, Department of Neurosurgery

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
only surgeon knows the used technique, endocrinologist, patient and all involved medical staff is blinded
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: prospective randomized
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 14, 2018

First Posted

May 3, 2018

Study Start

May 10, 2018

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

May 17, 2023

Record last verified: 2023-05

Locations